The Scientific and Regulatory Advisors team at Bexion Pharmaceuticals plays a pivotal role in guiding the development of innovative oncology treatments. This team comprises experts who provide scientific insights and strategic regulatory advice, ensuring that clinical trials are designed effectively and comply with industry regulations. Their collaborative efforts help balance scientific rigor with commercialization strategies, ultimately advancing Bexion’s mission to meet the critical needs of cancer patients.
Adam Creighbaum
Senior Scientist
Andrew M. Lowy
Scientific Advisor
Erin Kraus
Clinical Trials Manager
Gilles Tapolsky
Pharmacology
Joanna Groden
Scientific Advisor
Nita J. Maihle
Scientific Advisor
Olivier Rixe
Clinical & Scientific Advisor
Richard J. Schwen
Regulatory Advisor
Shabnam Kazmi
Commercialization Advisor
Xiaoyang Qi
Scientific Advisor
View all